SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
Chinese company Sanjiang (02198) spent HKD 1.7455 million on repurchasing 1 million shares on September 11th.
HK Stock Market Move | CSTONE PHARMA-B(02616) rises more than 4%, CS2015 will debut at ACAAi 2025.
HK Stock Market Move | REPT BATTERO(00666) rose nearly 7% again, and several leading electric core manufacturers have continued to operate at full capacity. The company's shipments of energy storage batteries have significantly increased.
Chinese company Sanjiang (02198) spent HKD 1.7455 million on repurchasing 1 million shares on September 11th.
HK Stock Market Move | CSTONE PHARMA-B(02616) rises more than 4%, CS2015 will debut at ACAAi 2025.
HK Stock Market Move | REPT BATTERO(00666) rose nearly 7% again, and several leading electric core manufacturers have continued to operate at full capacity. The company's shipments of energy storage batteries have significantly increased.
RECOMMEND
Hong Kong Stock Concept Tracker｜Oracle (ORCL.US) RPO Surge Ignites AI Computing Power Chain—Domestic Opportunities in Focus
11/09/2025
Southbound Capital Flows Shift: Profit-Taking on High-Flying Stocks and Accumulating Alibaba and Tence
11/09/2025
Anti-Involution Policies Deliver Results as August Price Indicators Improve
11/09/2025
